Literature DB >> 12032128

Risk factors for microalbuminuria and macroalbuminuria in type 2 diabetic patients: a 9-year follow-up study.

Marcia Murussi, Pierangelo Baglio, Jorge L Gross, Sandra P Silveiro.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12032128     DOI： 10.2337/diacare.25.6.1101

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  9 in total

Review 1.  Should albuminuria be a focus of antihypertensive therapy goals?

Authors:  Radica Z Alicic; Sandeep A Saha; Robert A Short; Katherine R Tuttle
Journal:  Curr Hypertens Rep       Date:  2009-10       Impact factor: 5.369

2.  Six-Month Periodic Fasting in Patients With Type 2 Diabetes and Diabetic Nephropathy: A Proof-of-Concept Study.

Authors:  Alba Sulaj; Stefan Kopf; Ekaterina von Rauchhaupt; Elisabeth Kliemank; Maik Brune; Zoltan Kender; Hannelore Bartl; Fabiola Garcia Cortizo; Katarina Klepac; Zhe Han; Varun Kumar; Valter Longo; Aurelio Teleman; Jürgen G Okun; Jakob Morgenstern; Thomas Fleming; Julia Szendroedi; Stephan Herzig; Peter P Nawroth
Journal:  J Clin Endocrinol Metab       Date:  2022-07-14       Impact factor: 6.134

Review 3.  COVID-19 and the hidden threat of diabetic microvascular complications.

Authors:  Hadeel Zaghloul; Rayaz A Malik
Journal:  Ther Adv Endocrinol Metab       Date:  2022-07-11       Impact factor: 4.435

4.  A longitudinal study of risk factors for incident albuminuria in diabetic American Indians: the Strong Heart Study.

Authors:  Jiaqiong Xu; Elisa T Lee; Richard B Devereux; Jason G Umans; Jonathan N Bella; Nawar M Shara; Jeunliang Yeh; Richard R Fabsitz; Barbara V Howard
Journal:  Am J Kidney Dis       Date:  2008-03       Impact factor: 8.860

5.  Soluble urokinase receptor (suPAR) predicts microalbuminuria in patients at risk for type 2 diabetes mellitus.

Authors:  Martina Guthoff; Robert Wagner; Elko Randrianarisoa; Erifili Hatziagelaki; Andreas Peter; Hans-Ulrich Häring; Andreas Fritsche; Nils Heyne
Journal:  Sci Rep       Date:  2017-01-16       Impact factor: 4.379

6.  Galectin-3 as a prognostic biomarker for diabetic nephropathy.

Authors:  Hossam Hodeib; Maha M Hagras; Dina Abdelhai; Mona M Watany; Amal Selim; Mohamed A Tawfik; Mohamed A Elsebaey; Samah A Elshweikh
Journal:  Diabetes Metab Syndr Obes       Date:  2019-03-13       Impact factor: 3.168

7.  Diabetic nephropathy.

Authors:  Themis Zelmanovitz; Fernando Gerchman; Amely Ps Balthazar; Fúlvio Cs Thomazelli; Jorge D Matos; Luís H Canani
Journal:  Diabetol Metab Syndr       Date:  2009-09-21       Impact factor: 3.320

8.  Albuminuria Testing in Hypertension and Diabetes: An Individual-Participant Data Meta-Analysis in a Global Consortium.

Authors:  Jung-Im Shin; Alex R Chang; Morgan E Grams; Josef Coresh; Shoshana H Ballew; Aditya Surapaneni; Kunihiro Matsushita; Henk J G Bilo; Juan J Carrero; Gabriel Chodick; Kenn B Daratha; Simerjot K Jassal; Girish N Nadkarni; Robert G Nelson; Christoph Nowak; Nikita Stempniewicz; Keiichi Sumida; Jamie P Traynor; Mark Woodward; Yingying Sang; Ron T Gansevoort
Journal:  Hypertension       Date:  2021-08-09       Impact factor: 9.897

Review 9.  Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature review.

Authors:  Andréa D Bertoldi; Panos Kanavos; Giovanny V A França; André Carraro; Cesar Augusto Ovieda Tejada; Pedro C Hallal; Alessandra Ferrario; Maria Inês Schmidt
Journal:  Global Health       Date:  2013-12-03       Impact factor: 4.185
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.